This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Citation map  • Citing articles on HighWire  • Citing articles on Web of Science (1)  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Eight Years Later

Mary E. Costanza, MD

JAMA. 1984;252(18):2611-2612.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

JUST a little over eight years ago I expressed my concerns¹ about the uncritical and premature acceptance of the results of the then recently published adjuvant study by the National Surgical Breast Project (NSABP).² The NSABP report detailed early results of a randomized study of patients who had undergone mastectomy with axillary lymph nodes treated either with phenylalanine or placebo. The publication created tremendous excitement and enthusiasm, both in the medical community and in the press. There were those who believed that the cure of cancer was just around the corner,³ and others who believed that the whole matter was greatly overexaggerated.⁴ Now, eight years later, we have seen innumerable reports of studies utilizing adjuvant chemotherapy, principally in the treatment of stage II breast cancer, but also in other tumors, such as gastric, melanoma, and colon cancer. Several things have become obvious over the intervening years. On . . . [Full Text PDF of this Article]

Author Affiliations
From the Division of Oncology, the University of Massachusetts Medical School/Center, Worcester.

Footnotes
Reprint requests to the Division of Oncology, the University of Massachusetts Medical School, Worcester, MA 01605 (Dr Costanza).

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?